Get the Stockscreener App
28.59
8.01%
2.12
Twist Bioscience Corp stock is traded at $28.59, with a volume of 1.09M.
It is up +8.01% in the last 24 hours and down -20.21% over the past month.
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
See More
Previous Close:
$26.47
Open:
$26.55
24h Volume:
1.09M
Relative Volume:
0.83
Market Cap:
$1.73B
Revenue:
$362.27M
Net Income/Loss:
$-85.19M
P/E Ratio:
-19.72
EPS:
-1.45
Net Cash Flow:
$-68.71M
1W Performance:
+1.67%
1M Performance:
-20.21%
6M Performance:
-30.79%
1Y Performance:
-32.67%
1-Day Range:
$26.47
$28.78
1-Week Range:
$25.73
$28.78
52-Week Range:
$24.28
$55.33
Twist Bioscience Corp Stock (TWST) Company Profile
Name
Twist Bioscience Corp
Sector
Industry
Phone
800-719-0671
Address
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
28.59 | 1.69B | 362.27M | -85.19M | -68.71M | -1.45 |
|
TMO
Thermo Fisher Scientific Inc
|
499.99 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
211.80 | 149.66B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
645.55 | 51.03B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
121.63 | 33.56B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
191.15 | 32.73B | 15.70B | 1.24B | 2.01B | 6.91 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Jun-04-24 | Initiated | Guggenheim | Buy |
| Jan-17-24 | Upgrade | Goldman | Neutral → Buy |
| Sep-27-23 | Initiated | Berenberg | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-03-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-29-21 | Initiated | William Blair | Outperform |
| Jun-04-21 | Initiated | Goldman | Neutral |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Feb-05-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-20 | Initiated | SVB Leerink | Mkt Perform |
| May-31-19 | Initiated | Evercore ISI | Outperform |
| Nov-26-18 | Initiated | JP Morgan | Neutral |
View All
Twist Bioscience Corp Stock (TWST) Latest News
Twist Bioscience Launches Oncology DNA CGP Panel to Advance Precision Medicine with Customizable, Platform-Agnostic NGS Solution - Business Wire
Leading vs lagging indicators on Twist Bioscience Corporation performanceJuly 2025 Momentum & Reliable Intraday Trade Plans - Newser
What risks could impact Twist Bioscience Corporation stock performance2025 Earnings Impact & Low Volatility Stock Recommendations - Newser
Twist Bioscience Corporation recovery potential after sell offTrade Volume Summary & Low Volatility Stock Suggestions - Newser
Why Twist Bioscience Corporation is moving todayJuly 2025 Summary & Proven Capital Preservation Tips - Newser
Analyzing net buyer seller activity in Twist Bioscience CorporationJuly 2025 Levels & Low Risk Entry Point Guides - Newser
William Blair Has Bullish Forecast for TWST FY2025 Earnings - Defense World
Improving Crop Resilience with AI and DNA Synthesis - the-scientist.com
After Plunging 33.8% in 4 Weeks, Here's Why the Trend Might Reverse for Twist Bioscience (TWST) - Yahoo Finance
Twist Bioscience Third Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Why Investors Shouldn't Be Surprised By Twist Bioscience Corporation's (NASDAQ:TWST) 27% Share Price Plunge - 富途牛牛
Twist Bioscience Price Target Cut Amid Revenue Pressures: Analyst Downgrades Valuation to $36, Keeps Buy Rating - AInvest
Twist Bioscience Reports Record Revenue and Narrowed Guidance Amid Challenges - AInvest
Twist Bioscience’s DNA Ambitions Face Growth And Profit Hurdles - Finimize
Finn, Twist Bioscience COO, sells $90k in shares By Investing.com - Investing.com Nigeria
Cho Dennis, SVP at Twist Bioscience, sells $22k in shares - Investing.com Nigeria
Cho Dennis, SVP at Twist Bioscience, sells $22k in shares By Investing.com - Investing.com South Africa
Leproust, Twist Bioscience CEO, sells $158k in stock By Investing.com - Investing.com Canada
Finn, Twist Bioscience COO, sells $90k in shares - Investing.com
Werner, Twist Bioscience CAO, sells $5275 in TWST stock By Investing.com - Investing.com Australia
Werner, Twist Bioscience CAO, sells $5275 in TWST stock - Investing.com India
Green Paula, SVP at Twist Bioscience, sells $35k in shares - Investing.com
Leproust, Twist Bioscience CEO, sells $158k in stock - Investing.com India
Twist Bioscience Executives Sell Shares to Cover Tax Obligations - TradingView
Twist Bioscience Corporation (NASDAQ:TWST) Q3 2025 Earnings Call Transcript - Insider Monkey
Twist Bioscience stock hits 52-week low at 27.12 USD By Investing.com - Investing.com South Africa
Twist Bioscience stock hits 52-week low at 27.12 USD - Investing.com India
Twist Bioscience appoints Trynka Shineman Blake to board of directors - Investing.com
Twist Bioscience Appoints Trynka Shineman Blake to Board of Directors - Business Wire
A Quick Look at Today's Ratings for Twist Bioscience(TWST.US), With a Forecast Between $25 to $46 - 富途牛牛
JPMorgan lowers Twist Bioscience stock price target to $25 from $33 - Investing.com
Twist Bioscience Corp (TWST) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance
Can Traders Expect Breakout From Twist Bioscience Corporation This WeekEntry Zone Strategy for Consistent Profit Shared - metal.it
Twist Bioscience Corp SEC 10-Q Report - TradingView
Twist Bioscience Turns The Tide: Q3 Sales Jump, Beats Earnings - Benzinga
Twist Bioscience earnings beat by $0.86, revenue topped estimates - Investing.com
Twist Bioscience stock price target lowered to $36 by TD Cowen - Investing.com South Africa
Twist Bioscience: Fiscal Q3 Earnings Snapshot - The Washington Post
Evercore ISI lowers Twist Bioscience stock price target on revenue timing - Investing.com
Evercore ISI lowers Twist Bioscience stock price target on revenue timing By Investing.com - Investing.com South Africa
Twist Bioscience (TWST) Shares Drop 16.4% on Market Movements - GuruFocus
Earnings call transcript: Twist Bioscience Q3 2025 sees revenue rise 18% By Investing.com - Investing.com South Africa
Earnings call transcript: Twist Bioscience Q3 2025 sees revenue rise 18% - Investing.com Nigeria
Twist Bioscience (TWST) Q3 Profit Surges - The Motley Fool
Twist Bioscience (TWST) Q3 Profit Surges - Nasdaq
Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results - TradingView
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Twist Bioscience Q3 2025 slides: revenue hits $96.1M as margins exceed 50% target - Investing.com Canada
Will a bounce in Twist Bioscience Corporation offer an exitFree Real Time Alerts Based on AI Prediction - Newser
Using portfolio simulators with Twist Bioscience Corporation includedFree Stock Market Entry Timing Signals - Newser
Will Twist Bioscience Corporation benefit from macro trendsPredictive Model for Intraday Swing Forecast - Newser
Twist Bioscience Corp Stock (TWST) Financials Data
Revenue
Net Income
Cash Flow
EPS
Twist Bioscience Corp Stock (TWST) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Leproust Emily M. | Chief Executive Officer |
Aug 04 '25 |
Sale |
28.36 |
5,585 |
158,413 |
639,721 |
| Green Paula | SVP of Human Resources |
Aug 04 '25 |
Sale |
28.36 |
1,255 |
35,597 |
126,206 |
| Cho Dennis | See Remarks |
Aug 04 '25 |
Sale |
28.36 |
785 |
22,266 |
103,827 |
| Finn Patrick John | President and COO |
Aug 04 '25 |
Sale |
28.36 |
3,189 |
90,453 |
235,153 |
4.05%
1.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):